Which of the following is a common adverse effect associated with Nebivolol?

Nebivolol is a selective beta-1 adrenergic antagonist primarily used in the treatment of hypertension and heart failure. One of its distinguishing features is that it has a favorable side effect profile compared to other beta-blockers. The correct answer indicates that "None" is a common adverse effect associated with Nebivolol, which highlights its relative safety in terms of side effects.

Although some patients may experience minor adverse effects, Nebivolol is less likely to cause the specific side effects listed, such as dry mouth, drowsiness, and weight gain. Dry mouth is more commonly associated with medications that have anticholinergic properties, while drowsiness can occur with other types of beta-blockers, especially those that are less selective. Weight gain is often observed with various antihypertensives, particularly with certain classes of medications, but Nebivolol is typically not associated with this side effect due to its unique mechanism of action and the metabolic benefits it may confer.

Thus, acknowledging that there are no common adverse effects associated with Nebivolol reinforces the understanding of its therapeutic benefits and differentiates it from other medications in its class.